GHIC is an organization focused on driving innovation in global public health.
A pioneer of investing in global health, GHIC has been supporting high impact biomedical innovations for nearly a decade. Our inaugural Global Health Investment Fund (GHIF) financed the development of new products to combat urgent public health challenges that disproportionately affect people living in low- and middle-income countries. Building on the success of GHIF, we have expanded our mission to pursue additional partnerships to develop and commercialize health technologies to strengthen global health security.
The Global Health Investment Corporation was established as an independent not-for-profit corporation whose mission is to mobilize private, public and philanthropic capital to accelerate the development, commercialization and access to products and technologies to improve global health and strengthen global health security.
In 2012, the Gates Foundation sponsored the creation of GHIC and the launch of its initial fund, the Global Health Investment Fund, with the support of JP Morgan Chase. The original vision was to apply well-established venture capital practices using blended finance to accelerate the development of products and technologies that would improve lives globally by addressing high-burden global health challenges.
"We invest in global health because we know that when health improves, life improves by every measure." – Bill Gates, Chair, Gates Foundation
The Government of Germany, acting through the German Federal Ministry for Economic Cooperation and Development (BMZ) and the KfW Development Bank, helped capitalize GHIC with an initial grant and remains a key strategic partner and funder of GHIC.
Other GHIF stakeholders and investors include Grand Challenges Canada, the Swedish International Development Agency, the International Finance Corporation, GSK, Merck, Pfizer, AXA Investment Managers, Storebrand, JP Morgan Social Finance, the Children’s Investment Fund Foundation, along with other foundations and individual investors.
Since its launch, GHIF's success has inspired the launch of other impact investment funds, many with GHIC’s support and collaboration.
In 2021, GHIC entered into a 10-year venture investment partnership with the Biomedical Advanced Research and Development Authority (BARDA) focused on global health security. BARDA will provide GHIC with funding, as well as scientific and technical input, and GHIC will mobilize additional third-party capital to finance the development of technologies to respond to or prevent future pandemics and other health security threats.